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a b s t r a c t
Some viruses and most eukaryotic cells have microRNAs that regulate the expression of many genes.
Although many viral miRNAs have been identiﬁed, only a few have been included in in vivo functional
studies. Here we show that a Py-encoded miRNA downregulates the expression of the pro-apoptotic
factor Smad2, resulting in the suppression of the apoptosis pathway. To study the Py miRNA in an in vivo
context, a miRNA-deﬁcient mutant virus was created on the background of the LID virus strain which
establishes a rapid and lethal infection in newborn mice. Apoptosis analysis on kidney tissues indicates
that the pro-apoptotic pathway is targeted in the infected host as well. Suppression of apoptosis through
targeting of Smad2 by the Py miRNA is expected to synergize with anti-apoptotic effects previously
attributed to the polyoma tumor antigens in support of virus replication in the natural host.
& 2014 Elsevier Inc. All rights reserved.
Introduction
MicroRNAs (miRNAs) are non-coding small RNAs that regulate
the expression of many genes and have been proposed as useful
biomarkers for diverse diseases with possibly therapeutic implica-
tions. Most eukaryotic cells have been conﬁrmed to utilize miRNAs
for posttranscriptional gene regulation (Bartel, 2009; Garzon et al.,
2009; Kumar et al., 2007). Some viruses including retrovirus,
herpesvirus and polyomavirus have been shown to encode miRNAs
that are involved in the regulation of viral replication, immune
evasion and cellular apoptotic pathways (Cullen, 2010; Dahlke et al.,
2012; Grundhoff and Sullivan, 2011; Imperiale, 2014; Kincaid and
Sullivan, 2012; Pfeffer et al., 2004; Sullivan et al., 2005).
Studies of the highly oncogenic mouse polyomavirus (Py) have
identiﬁed viral replicative and transforming functions as well as
genetic determinants of the host that underlie susceptibility or
resistance to tumor induction by the virus (Benjamin, 2001, 2007).
Decades of investigations have revealed the virus's structural,
molecular, biological, and genetic characteristics and how they
affect virus replication, cell transformation and tumorigenesis
(Imperiale and Major, 2007). The protein networks altered in
Py-induced oncogenesis overlap with those affected in many
human cancers (Cheng et al., 2009; Fluck and Schaffhausen,
2009; Freund et al., 1994; Rozenblatt-Rosen et al., 2012). The ﬁrst
identiﬁcation of a miRNA encoded by a polyomavirus was in SV40
where it was shown to target and downregulate the overlapping
large T antigen. This study raised the intriguing possibility that this
miRNA might serve as part of an immune evasion mechanism
(Sullivan et al., 2005). We subsequently identiﬁed an analogous Py
miRNA with an autoregulatory role downregulating early viral
gene expression (Sullivan et al., 2009). Results of attempts to
demonstrate an effect of the Py miRNA on immune evasion or viral
clearance in vivo were negative (Sullivan et al., 2009). The results
of this initial study were inconclusive with respect to demonstrat-
ing or ruling out a physiological role of the Py miRNA. Here we
turn our attention to host genes as possible targets of Py miRNA
and show that the pro-apoptotic factor Smad2 is downregulated
by Py miRNA resulting in suppression of apoptosis in vivo.
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Results
The Py microRNA targets Smad2 and reduces the apoptotic rate
in infected cells
We have previously identiﬁed Py-encoded miRNAs (Sullivan
et al., 2009) and showed that they inhibit Py large and middle
T (tumor) antigen expression. To investigate their possible roles in
the regulation of host gene expression, we ﬁrst turned to bioinfor-
matic target prediction programs. Interestingly, one of the putative
targets predicted by TargetScanMouse Custom Version 5.1 (Lewis
et al., 2005) was TgfβRI, while another web-based program
RNAhybrid (Kruger and Rehmsmeier, 2006) predicted Smad2 as
a potential target of Py-miRNA. The putative binding site in the
Smad2 30UTR region is shown in Fig. 1A and Supplementary Fig. 1.
The ability to block apoptotic responses of the host is critical
particularly for viruses such as polyoma with long replication
cycles (36–48 h). Since TgfβRI and Smad2 are important regulators
of the programmed cell death machinery (Heldin et al., 2009;
Hough et al., 2012; Moustakas and Heldin, 2009), we undertook
further investigations of TgfβRI and Smad2 as possible targets of
the Py miRNA.
We ﬁrst infected baby mouse kidney cells with wild type virus
(PTA) or miRNA-deﬁcient mutant virus (PTA-dl1013) (Magnusson
and Berg, 1979; Sullivan et al., 2009) to determine whether the
expression levels of TgfβRI and Smad2 are altered by Py-miRNA.
Cell lysates were prepared at 40 h post-infection and subjected to
western blot analysis. The protein level of TgfβRI was not altered
by viral infection (data not shown). The Smad2 protein, however,
was downregulated by the wild type but not by the mutant virus.
The level of Smad2 in mutant infected cells remained similar to
that of the uninfected control (Fig. 1B). These results suggest that
Py-miRNA may be involved in the repression of Smad2.
As targeting the host's programmed cell death pathway would
be advantageous if not essential for viral infections, an apoptosis
analysis with the wild type and mutant strains was performed.
Mouse kidney epithelial cells (IMCD) were infected with PTA or
mutant PTA-dl1013 and treated with etoposide (25 mM for 16 h) to
induce apoptosis. Cell lysates were mixed with ﬂuorogenic pep-
tides as substrates for proapoptotic caspase-3. The caspase-3
enzyme activity was signiﬁcantly reduced in the wild type PTA-
infected cells compared to that in miRNA-deﬁcient mutant-
infected cells or the uninfected control. These results indicate that
Py miRNA targets the host's apoptotic pathway by downregulating
Smad2 (Fig. 1C).
Lentiviruses harboring Py-shRNA targets Smad2 and the apoptotic
pathway
To independently test the role of Py short hairpin (Py-shRNA,
precursor to Py miRNA) in suppressing programmed cell death, we
generated a lentiviral vector harboring the Py-shRNA (Fig. 2A).
Lentiviral particles with Py-shRNA were prepared along with
empty vector control lentivirus (pLKO) and used to infect IMCD
cells. First its ability to downregulate the expression of Smad2 was
reexamined by western blot. As shown in Fig. 2B, Smad2 protein
levels are reduced with Py-shRNA-harboring lentivirus compared
to those of control virus- infected cells, indicating that the
introduction of Py-shRNA-harboring lentiviral particles into mouse
cells leads to decreased expression of Smad2. To determine if the
30UTR region of Smad2 is important for the target recognition and
inhibition by Py-shRNA, pMIR-luciferase vectors with or without
the 30UTR region of Smad2 were constructed and used in dual
luciferase assays. IMCD cells were transfected with pRenilla and
pMIR control, pMIR-Smad2-30UTR or pMIR-Smad2-30UTR deleted
vector, and then infected with control lenti or lenti with Py-shRNA.
At 48 h post-infection, cells were lysed and subjected to a
luciferase analysis (Fig. 2C). The enzyme activity of vector includ-
ing 30UTR of Smad2 was signiﬁcantly reduced with lenti-Py-
shRNA, but the vector lacking the 30UTR of Smad2 did not show
any difference with lenti-Py-shRNA, demonstrating that Py-shRNA
represses the expression of Smad2 by targeting its 30UTR region.
TUNEL assays were also performed to test whether the
Py-shRNA is involved in blocking apoptosis. IMCD cells on cover-
slips were infected with lenti-pLKO or lenti-Py-shRNA, treated
with DMSO or etoposide, then ﬁxed and TUNEL assayed for
apoptosis. The number of apoptotic cells (red) was counted in
each sample and compared (Fig. 2D). More apoptotic cells were
seen with control lenti-pLKO than with lenti-Py-shRNA. Moreover,
under conditions of etoposide treatment to induce apoptosis, the
Fig. 1. The Py-miRNA targets Smad2 and results in reduced apoptosis. (A) Sequence comparison between Py-miRNA and murine Smad2 30UTR. (B) Western blot of Smad2
expression among uninfected, WT-infected, and miRNA-deﬁcient mutant Py-infected baby mouse kidney cells. Smad2 expression is lowered with WT Py virus, but not with
miRNA-deﬁcient mutant Py. (C) Caspase 3 activity assay of WT-infected and miRNA-deﬁcient mutant Py-infected IMCD cells treated with etoposide. WT but not mutant virus
inhibits etoposide induced apoptosis (nnp-Value o0.01).
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Fig. 2. Lentiviruses harboring Py-shRNA also target Smad2 and the pro-apoptotic pathway. (A) Polyomavirus short hairpin is inserted into pLKO generating a Py-shRNA
lentiviral clone that is used in immunoblotting and apoptosis assays (red nucleotides, estimated position of the 5p miRNA; blue nucleotides, estimated position of the 3p
miRNA). (B) Smad2 protein expression is reduced with Py-shRNA lentivirus in infected IMCD cells. (C) pMIR-Luciferase-Smad2-30UTR shows reduced luciferase activities with
Lenti-Py-shRNA while control pMIR and pMIR-Smad2-30UTR mutant vectors show no changes with Lenti-Py-shRNA (nnp-Value o0.01). (D) Mouse IMCD cells are infected
with control or Py-shRNA lentivirus, then treated with either DMSO or etoposide. Infected cells are ﬁxed on coverslips, and TUNEL assays are performed to compare the rates
of apoptosis. Left – Representative images of the TUNEL-assayed coverslips. Red: apoptotic; Blue: DAPI stain. Right – Apoptotic cells are counted in each sample and
normalized to control lentivirus infected, DMSO treated samples (np-Value o0.05; nn*p-Value o0.01).
Fig. 3. The apoptosis mechanism is targeted by the Py-miRNA in infected mice. Kidneys are harvested from C3H/BiDa mice neonatally-infected with LID Py or mutant, non-
miRNA expressing LID-dl1013 Py at day 8 post-injection. Kidney sections are subjected to apoptosis analyses (TUNEL) with the apoptosis marker anti-digoxigenin (red) and
anti-polyoma large T antigen (green) antibodies. (A) Representative images of kidney stains from each group. An uninfected kidney sample is shown as a control.
(B) Quantiﬁcation of apoptosis rates in the LID and LID-dl1013 infected groups. The percentage of cells that double-stained for apoptosis and Py-infection is quantiﬁed
between the two groups. Roughly 3000 infected cells from each group are counted and plotted (nnp-Value o0.01).
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lenti-Py-shRNA strongly inhibited the response conﬁrming that
the Py-shRNA functions to block apoptosis.
The Py miRNA inhibits apoptosis in kidneys of infected mice
A previous study using wild type and microRNA-deﬁcient
mutant viruses on a standard wild type (PTA) virus background
showed similar levels of infection in kidneys of neonatally infected
mice (Sullivan et al., 2009). The overall infection rate was low,
however, possibly obscuring differences. Here we investigate the
role of the Py miRNA by comparing wild type and mutant viruses
on the background of the LID virus strain. LID is a highly virulent
strain of Py that induces a lethal infection of newborn mice (Bauer
et al., 1995; Bolen et al., 1985). Mice succumb within a few weeks
due to a widely disseminated infection accompanied by extensive
tissue destruction most prominently in the kidney. LID owes its
virulence to a single amino acid substitution in the major capsid
protein VP1 (V296A) which reduces its van der Waals interaction
with sialic acid receptors. The lower avidity of receptor binding by
LID facilitates release from cell debris and promotes virus spread.
We reasoned that by virtue of LID's ability to induce an acute and
rapidly spreading infection, an effect of the Py miRNAs could be
more readily assessed using this viral genetic background. New-
born mice were injected with LID or LID-dl1013 and sacriﬁced at
day 8 post-injection. Kidney sections from age-matched unin-
fected mice were prepared as controls. The ﬁxed slides were
incubated with anti-digoxigenin (red) and anti-polyoma large
T antigen (green) antibodies to identify and quantify apoptotic
cells among infected cells. Roughly 3000 infected cells from seven
LID and 10 LID-dl1013-injected mice were examined by ﬂuores-
cence microscopy. As shown in Fig. 3A and B, the percentages of
apoptotic cells in kidneys of LID-dl1013-infected mice are signiﬁ-
cantly higher than in kidneys of LID-infected mice, conﬁrming that
Py miRNA blocks apoptosis in the infected host.
Discussion
Viruses have to prevent rapid cell death responses by their host
cells for efﬁcient infection and spread. This is particularly critical
for viruses such as those of the polyoma group whose replication
cycles are long (36–48 h) compared to typical host apoptotic
responses (4–8 h) (Spencer and Sorger, 2011). In this report, we
have used target prediction tools and biochemical approaches to
identify the proapoptotic factor Smad2 as a target of downregula-
tion by the Py miRNA. The miRNA-mediated pathway of apoptosis
inhibition by polyoma is expected to synergize with other anti-
apoptotic effects previously attributed to the polyoma viral
T antigens. The polyoma middle T antigen inhibits apoptosis by
activating the PI3-kinase-Akt pathway (Dahl et al., 1998) and the
large T antigen by interaction with p150, a transcription factor
with pro-apoptotic and growth arrest functions (Gu et al., 2011;
Li et al., 2001; Li et al., 2004; Liu et al., 2007). Polyoma thus
employs overlapping and potentially redundant mechanisms to
inhibit apoptotic responses of the host, utilizing both early
(T antigens) and late (PymiRNA) gene expression.
Several viral miRNAs have been shown to target proapoptotic
genes of their hosts. Epstein–Barr virus-encoded miRNA targets the
pro-apoptotic gene PUMA as well as another pro-apoptotic gene Bim
(Choy et al., 2008; Marquitz et al., 2011), and Marek's disease virus
type 1 (MDV1)-encoded miRNA suppresses apoptosis in cell culture
by targeting Smad2 (Xu et al., 2011). The functional importance of
viral miRNAs during infection of the natural host has not always
been possible to establish. To explore the functions of the Py miRNA
in the mouse, we generated a miRNA-deﬁcient mutant virus on the
background of the virulent LID strain. The mutant virus was
signiﬁcantly less effective than the wild type in blocking apoptosis.
This was examined in kidneys of neonatally infected mice which
serve as the major site of virus ampliﬁcation. Inhibition of apoptosis
is expected to result in enhanced infection not only in the kidney but
also in other vital tissues. Further studies will be needed to evaluate
the role of Py miRNA in the establishment of acute as well as long
term persistent infection, induction of tumors, as well as interactions
with the host immune system.
The Py miRNA may target cellular genes in addition to Smad2.
miRNAs of other members of the polyomavirus family have been
shown or predicted to target a variety of cellular genes that serve
the virus in terms of promoting virus replication or evading
recognition by the host immune system. Human polyomaviruses
BK and JC possess an identical miRNA which targets the stress-
induced ligand ULBP3, and this inhibition contributes to immune
evasion (Bauman et al., 2011). Human genes that are involved in B
cell proliferation or cell cycle modulation have been predicted as
potential targets of the Merkel cell polyomavirus-encoded miRNA
although they await further validation (Lee et al., 2011). DUSP8
(M3/8), a negative regulator of c-Jun N-terminal kinases (JNK), is
targeted by SV40-encoded miRNA, indicating that SV40 miRNA
may be involved in the regulation of MAPK pathways (Chen et al.,
2013; Muda et al., 1996). The miRNAs encoded by these small DNA
viruses provide an efﬁcient way to regulate the expression of
multiple genes of their hosts.
Materials and methods
Cells
Baby mouse kidney cells were grown in DMEM with 10%
newborn calf serum, and 293 FT, NIH 3T3 and IMCD mouse kidney
epithelial cells were grown in DMEM with 10% fetal bovine serum.
Plasmids and viruses
The pMIR luciferase reporter (Life Technologies, Carlsbad, CA,
USA) was used to clone mouse Smad2 30UTR. PCR fragments were
prepared with a primer set 50 TTACTAGTCTAGGAGTAAAGG-
GAGCGGGTTGG and 50 TTAAGCTTCAATGGGGTACAATGCTGTAA for
WT and a primer set 50 TTACTAGTCTAGGAGTAAAGGGAG-
CGGGTTGG and 50 TTAAGCTTTGGCTGGCTAAGGAGTGACAAGAAC
for the deletion mutant. Each insert was cloned into the HindIII/
SpeI site (downstream of the luciferase reporter gene) of the pMIR
vector, and their structures were conﬁrmed by sequencing. The
pRL-TK vector was from Promega (Madison, WI, USA).
The lenti viral vector pLKO (Sigma Aldrich, St Louis, MO, USA)
was used to clone the Py short hairpin with these synthetic
nucleotides:
PyshF 50CCGGGGGGGGGGATGAGCTGGGGTACTTGTTCCTCCGG-
TAGGATGTCCAAATACAGATCCTCCATTGGCATGTACTCCTCCTCCTCC-
TCCTCCTTTTTG
and PyshR 50AATTCAAAAAGGAGGAGGAGGAGGAGGAGTACAT-
GCCAATGGAGGATCTGTATTTGGACATCCTACCGGAGGAACAAGTACC-
CCAGCTCATCCCCCCCC.
The newly constructed pLKO-Py-shRNA was sequenced to
conﬁrm its structure and used to make lenti viral particles in
293 FT cells with ViraPower Packaging Mix (Life Technologies). The
viral supernatants were harvested after 48–72 h, spun at
3000 rpm for 10 min and ﬁltered with 0.45 mm Millex syringe
ﬁlters (EMD Millipore Corporation, Billerica, MA, USA). Virus was
then concentrated by mixing with 5X PEG precipitation solution
(40% Polyethylene Glycol, 0.4 M NaCl and 2 mM EDTA), stored
overnight at 4 1C and centrifuged at 3000 rpm for 30 min. Pelleted
virus was resuspended in PBS buffer and stored at 80 1C.
C.K. Sung et al. / Virology 468-470 (2014) 57–6260
A LID version of dl1013 (a derivative of the strain A2) was
constructed with QuikChange site-directed mutagenesis kit (Agi-
lent Technologies, La Jolla, CA, USA), a primer set (50–GGAGTA-
CATGCCAATGGAACCGGAGGAACAAGTACCCC/50–GGGGTACTTGTTC-
CTCCGGTTCCATTGGCATGTACTCC) and LID-pBluescript plasmid
DNA as a template. After conﬁrming the structure, the virus
portion of the plasmid was transfected into NIH 3T3 cells, and
viruses were harvested at 9 days post-transfection.
Py-miRNA target predictions
The seed sequences (50 GGGGUAC and 50 CCAUUGG) of the
Py-miRNAs were analyzed with TargetScanMouse Custom Version
5.1 (Lewis et al., 2005) for prediction of targets. Another web-
based program RNAhybrid (Kruger and Rehmsmeier, 2006) was
employed to predict the Py-miRNA binding sites in 30UTR regions
of mouse genes.
Immunoblot analysis
Cells were lysed in PBS containing 1% NP40 and protease
inhibitors (Roche, South San Francisco, CA, USA). Immunoblotting
was carried out on cell extracts using an Odyssey infrared imaging
system (LI-COR Biosciences, Lincoln, NE).
Fluorometric caspase-3 activity assay
Fifty micrograms of whole-cell lysates was incubated with
200 nM Ac-DEVD-AMC (Ac is N-acetyl, DEVD is Asp–Glu–Val–
Asp, and AMC is 7-amino-4-methylcoumarin) (BD Biosciences;
Franklin Lakes, NJ) in reaction buffer (20 mM HEPES [pH 7.4],
2 mM dithiothreitol [DTT], 10% glycerol) at 37 1C for 1 h. The
reaction was monitored by ﬂuorescence emission at 465 nm
(excitation at 360 nm) and measured with a ﬂuorescence plate
reader.
Luciferase dual assays
The vectors pRL-TK and pMIR, pMIR-mSmad2 30URT WT or
pMIR-mSmad2 30URT del mutant were introduced into IMCD cells
with Lipofectamine 2000 (Life Technologies), and then these cells
were infected with control lenti or lenti-Py-shRNA. After 48 h of
incubation at 37 1C, cells were subjected to luciferase activity
assays (Dual-Luciferase Reporter System). Fireﬂy luciferase values
were normalized to those of Renilla luciferase.
TUNEL assays
All mice were bred and maintained in a speciﬁc-pathogen-free
animal facility at Harvard Medical School. Protocols for animal
studies have been reviewed and approved by the Harvard Medical
Area Standing Committee on Animals (“HMA IACUC”), and are in
accordance with PHS policy on Care and Use of Laboratory Animals
under the guidance of the Ofﬁce of Laboratory Animal Welfare
(OLAW) within the NIH.
New born C3H/BiDa mice were injected intraperitoneally with
50 μl of virus suspension containing 106 pfu of the LID or LID-
dl1013 strain of Py. Infected mice were then held in a dedicated
infected animal facility. Infected mice and uninfected control mice
(age-matched) were sacriﬁced 8 days post-inoculation, and the
kidney tissues were immediately removed and frozen. Tissue
section slides were prepared at the Harvard Rodent Histopathol-
ogy Core.
TUNEL assays were performed using ApopTag Red In Situ
Apoptosis Detection Kit (EMD Millipore Corporation) as described
in the manufacturer's protocols with slight modiﬁcations. Brieﬂy,
tissue sections were ﬁxed in neutral buffered formalin, washed
and incubated for 5 min in antigen retrieval solution (HistoReveal;
Abcam, Cambridge, MA, USA). After washing, they were treated
with Proteinase K and then incubated with TdT enzyme for 1 h at
37 1C. After washing, they were incubated with 1:50 anti-Py tumor
antigen (generated in rat; Benjamin Lab) for 16 h at 4 1C. Then
Anti-digoxigenin conjugate (rhodamine) and anti-rat IgG (Oregon
Green) were used for 1 h at room temperature followed by
washing. Samples were mounted with a mounting medium con-
taining DAPI and viewed by ﬂuorescence microscopy.
For quantiﬁcation, stained slides were read by a researcher
blinded to the tissue source type using a Nikon Fluorescent
Microscope and accompanying software. Brieﬂy, for each tissue,
8–10 ﬁelds were chosen and imaged for red and green ﬂuores-
cence, with the merged images used to count the fraction of
infected (green-ﬂuorescing) cells that were concurrently under-
going apoptosis (red-ﬂuorescing). Results were averaged across all
tissues and the groups compared using t-tests.
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